THE SENATE

THE THIRTIETH LEGISLATURE

REGULAR SESSION OF 2020

 

COMMITTEE ON COMMERCE, CONSUMER PROTECTION, AND HEALTH

Senator Rosalyn H. Baker, Chair

Senator Stanley Chang, Vice Chair

 

NOTICE OF HEARING

 

 

DATE:

Thursday, March 12, 2020

TIME:

9:30 AM

PLACE:

Conference Room 229

State Capitol

415 South Beretania Street

 

A G E N D A

 

HB 1637, HD1

      (HSCR912-20)

      Status & Testimony

RELATING TO HEALTH.

Repeals the ceiling for using moneys in the civil monetary penalty special fund by DOH for compliance activities approved by the Centers for Medicare and Medicaid Services.  Appropriates funds to DOH for the establishment of a Medicare administrator position.  Effective 7/1/2050.  (HD1)

 

CPH, WAM

HB 1659, HD3

      (HSCR995-20)

      Status & Testimony

RELATING TO HEALTH.

Authorizes a pharmacy to provide a customized patient medication package to any person upon consent, with a valid prescription, and in compliance with labeling and dispensing requirements. Effective 07/01/2050.  (HD3)

 

CPH

HB 2097, HD2

      (HSCR948-20)

      Status & Testimony

RELATING TO MEDICAL CANNABIS.

Allows for a process to remediate any batch of cannabis or manufactured cannabis product that fails laboratory testing standards so long as any final cannabis or manufactured cannabis product passes all the laboratory standards.  Authorizes licensed dispensaries to manufacture and distribute edible cannabis products, under certain conditions, and circulate, sponsor, and promote educational and scientific information and events related to cannabis.  Effective 7/1/2050.  (HD2)

 

CPH, JDC/WAM

HB 2102, HD1

      (HSCR700-20)

      Status & Testimony

RELATING TO HEMP PRODUCTS.

Requires labels on hemp products.  Prohibits unwarranted health-related statements about hemp products.  Establishes standards for hemp product manufacturers.  Prohibits the manufacture or sale of any food into which a hemp product has been added.  Prohibits the sale of hemp products designed to appeal to children.  Establishes that a product shall not be considered adulterated or misbranded solely by the inclusion of hemp with certain exceptions.  Clarifies that a licensed medical cannabis dispensary is not prohibited from manufacturing, distributing, or selling products that contain hemp, or cannabinoids, extracts, or derivatives from hemp, subject to certain conditions.  Prohibits the sale of hemp products to persons under twenty-one years of age.  Requires DOH to report to the legislature.  Effective 7/1/2050.  Sunsets 6/30/2023.  (HD1)

 

CPH, WAM

HB 1805, HD1

      (HSCR789-20)

      Status & Testimony

RELATING TO PRESCRIPTION DRUGS.

Requires prescription drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale acquisition cost of certain drugs would result in a percentage increase of ten per cent or more than the percentage change in the Consumer Price Index over a two‑year period.  Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.  Effective 7/1/2050.  (HD1)

 

CPH

HB 2340, HD2

      (HSCR923-20)

      Status & Testimony

RELATING TO DEAD BODIES.

Clarifies prohibited actions related to anatomical gifts and disposition of bodies.  Effective 7/1/2050.  (HD2)

 

CPH, JDC

 

Decision Making to follow, if time permits.

 

Click here to submit testimony.

 

Testimony may be submitted up to 24 hours prior to the start of the hearing.

 

FOR AMENDED NOTICES:  Measures that have been deleted are stricken through and measures that have been added are underscored.  If a measure is both underscored and stricken through, that measure has been deleted from the agenda.

 

If you require auxiliary aids or services to participate in the public hearing process (i.e., interpretive services (oral or written), ASL interpreter, or wheelchair accessibility), please contact the committee clerk at least 24 hours prior to the hearing so that arrangements can be made.

 

FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT (808)586-6070.

 

 

 

_____________________________________

Senator Rosalyn H. Baker

Chair